Graham Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,746
| Closed | -$236K | – | 1295 |
|
|
2025
Q1 | $236K | Sell |
9,746
-15,159
| -61% | -$368K | ﹤0.01% | 1046 |
|
|
2024
Q4 | $520K | Sell |
24,905
-9,290
| -27% | -$194K | 0.01% | 696 |
|
|
2024
Q3 | $680K | Buy |
34,195
+16,686
| +95% | +$332K | 0.01% | 530 |
|
|
2024
Q2 | $271K | Buy |
+17,509
| New | +$271K | 0.01% | 739 |
|
|
2023
Q4 | – | Sell |
-24,173
| Closed | -$283K | – | 1026 |
|
|
2023
Q3 | $283K | Buy |
+24,173
| New | +$283K | 0.01% | 730 |
|
|
2022
Q2 | – | Sell |
-24,356
| Closed | -$201K | – | 1037 |
|
|
2022
Q1 | $201K | Buy |
+24,356
| New | +$201K | 0.01% | 820 |
|